SMART Health Cards: Vaccination & Testing Implementation Guide
1.0.0 - STU 1 International flag

SMART Health Cards: Vaccination & Testing Implementation Guide, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-shc-vaccination-ig/ and changes regularly. See the Directory of published versions

ValueSet: Immunization / All / CVX

Official URL: http://hl7.org/fhir/uv/shc-vaccination/ValueSet/immunization-all-cvx Version: 1.0.0
Standards status: Trial-use Maturity Level: 4 Computable Name: ImmunizationAllCvxValueSet

Contains all CVX codes from https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx as of 2025-09-03. This list of codes will not update automatically, so please refer to this URL for the most up-to-date codes.the most up-to-date codes.

References

Logical Definition (CLD)

  • Include these codes as defined in http://hl7.org/fhir/sid/cvx version ⏿20250715
    CodeDisplay
    54adenovirus, type 4
    55adenovirus, type 7
    82adenovirus, unspecified formulation
    24Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis
    19BCG
    27botulinum antitoxin
    26cholera, unspecified formulation
    29CMVIG
    56dengue fever tetravalent
    12diphtheria antitoxin
    28DT (pediatric)
    20DTaP
    106DTaP, 5 pertussis antigens
    107DTaP, unspecified formulation
    110DTaP-Hep B-IPV
    50DTaP-Hib
    120DTaP-Hib-IPV
    130DTaP-IPV
    22DTP-Hib
    102DTP-Hib-Hep B
    57hantavirus
    52Hep A, adult
    83Hep A, ped/adol, 2 dose
    84Hep A, ped/adol, 3 dose
    31Hep A, pediatric, unspecified formulation
    85Hep A, unspecified formulation
    104Hep A-Hep B
    30HBIG
    42Hep B, adolescent/high risk infant
    43Hep B, adult
    44Hep B, high-dosage, dialysis or IC
    45Hep B, unspecified formulation
    58Hep C
    59Hep E
    60herpes simplex 2
    46Hib (PRP-D)
    47Hib (HbOC)
    48Hib (PRP-T)
    49Hib (PRP-OMP)
    17Hib, unspecified formulation
    51Hib-Hep B
    61HIV
    118HPV, bivalent
    62HPV, quadrivalent
    86IG
    87IGIV
    14IG, unspecified formulation
    111Influenza, live, trivalent, intranasal, PF
    15influenza, split (incl. purified surface antigen)
    16influenza, whole
    88influenza, unspecified formulation
    123influenza, H5N1-1203
    10IPV
    89polio, unspecified formulation
    39Japanese encephalitis SC
    63Junin virus
    64leishmaniasis
    65leprosy
    66Lyme disease
    94MMRV
    67malaria
    68melanoma
    32meningococcal MPSV4
    103meningococcal C conjugate
    114meningococcal MCV4P
    108meningococcal ACWY, unspecified formulation
    69parainfluenza-3
    11pertussis
    23plague
    33pneumococcal polysaccharide PPV23
    100pneumococcal conjugate PCV 7
    109pneumococcal, unspecified formulation
    70Q fever
    18rabies, intramuscular injection
    40rabies, intradermal injection
    90rabies, unspecified formulation
    72rheumatic fever
    73Rift Valley fever
    34RIG
    119rotavirus, monovalent
    122rotavirus, unspecified formulation
    116rotavirus, pentavalent
    74rotavirus, tetravalent
    71RSV-IGIV
    93RSV-MAb
    38rubella/mumps
    76Staphylococcus bacterio lysate
    113Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
    115Tdap
    35tetanus toxoid, adsorbed
    112tetanus toxoid, unspecified formulation
    77Tick-borne encephalitis vaccine (non-US)
    13TIG
    95TST-OT tine test
    96TST-PPD intradermal
    97TST-PPD tine test
    98TST, unspecified formulation
    78tularemia vaccine
    91typhoid, unspecified formulation
    25typhoid, oral
    41typhoid, parenteral
    53typhoid, parenteral, AKD (U.S. military)
    101typhoid, ViCPs
    75Vaccinia (smallpox, mpox), live
    105vaccinia (smallpox) diluted
    79vaccinia immune globulin
    21varicella
    81VEE, inactivated
    80VEE, live
    92VEE, unspecified formulation
    36VZIG
    117VZIG (IND)
    37yellow fever live
    121zoster live
    998no vaccine administered
    999unknown
    99RESERVED - do not use
    133Pneumococcal conjugate PCV 13
    134Japanese Encephalitis IM
    137HPV, unspecified formulation
    136Meningococcal MCV4O
    135Influenza, high-dose, trivalent, PF
    131typhus, historical
    132DTaP-IPV-HIB-HEP B, historical
    128Novel Influenza-H1N1-09, all formulations
    125Novel Influenza-H1N1-09, nasal
    126Novel influenza-H1N1-09, preservative-free
    127Novel influenza-H1N1-09
    138Td (adult)
    139Td(adult) unspecified formulation
    140Influenza, split virus, trivalent, PF
    129Japanese Encephalitis, unspecified formulation
    141Influenza, split virus, trivalent, preservative
    142tetanus toxoid, not adsorbed
    143Adenovirus types 4 and 7
    144influenza, seasonal, intradermal, preservative free
    145RSV-MAb (new)
    146DTaP,IPV,Hib,HepB
    147meningococcal MCV4, unspecified formulation
    148Meningococcal C/Y-HIB PRP
    149Influenza, live, quadrivalent, intranasal
    150Influenza, split virus, quadrivalent, PF
    151influenza nasal, unspecified formulation
    152Pneumococcal Conjugate, unspecified formulation
    153Influenza, MDCK, trivalent, PF
    154Hep A, IG
    155Influenza, recombinant, trivalent, PF
    156Rho(D)-IG
    157Rho(D) -IG IM
    158Influenza, split virus, quadrivalent, preservative
    159Rho(D) - Unspecified formulation
    160Influenza A monovalent (H5N1), ADJUVANTED-2013
    801AS03 Adjuvant
    161Influenza, injectable,quadrivalent, preservative free, pediatric
    162meningococcal B, recombinant
    163meningococcal B, OMV
    164meningococcal B, unspecified
    165HPV9
    166influenza, intradermal, quadrivalent, preservative free
    167meningococcal, unknown serogroups
    168Influenza, adjuvanted, trivalent, PF
    169Hep A, live attenuated
    170DTAP/IPV/HIB - non-US
    171Influenza, MDCK, quadrivalent, PF
    172cholera, WC-rBS
    173cholera, BivWC
    174cholera, live attenuated
    175Rabies - IM Diploid cell culture
    176Rabies - IM fibroblast culture
    177PCV10
    178OPV bivalent
    179OPV ,monovalent, unspecified
    180tetanus immune globulin
    181anthrax immune globulin
    182OPV, Unspecified
    183Yellow fever vaccine live - alt
    184Yellow fever, unspecified
    185Influenza, recombinant, quadrivalent, PF
    186Influenza, MDCK, quadrivalent, preservative
    187zoster recombinant
    188zoster, unspecified formulation
    189HepB-CpG
    190Typhoid conjugate vaccine (TCV)
    191meningococcal A polysaccharide (non-US)
    192meningococcal AC polysaccharide (non-US)
    193Hep A-Hep B, pediatric/adolescent
    194Influenza, Southern Hemisphere
    195DT, IPV adsorbed
    196Td, adsorbed, preservative free, adult use, Lf unspecified
    197Influenza, high-dose, quadrivalent, PF
    200influenza, Southern Hemisphere, pediatric, preservative free
    201Influenza, Southern Hemisphere, quadrivalent, PF
    202influenza, Southern Hemisphere, quadrivalent, with preservative
    198DTP-hepB-Hib Pentavalent Non-US
    203meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
    205Influenza, adjuvanted, quadrivalent, PF
    206Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
    207COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
    208COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
    213SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
    210COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
    212COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
    204Ebola Zaire vaccine, live, recombinant, 1mL dose
    214Ebola, unspecified
    211COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
    500COVID-19 Non-US Vaccine, Product Unknown
    501COVID-19 IV Non-US Vaccine (QAZCOVID-IN)
    502COVID-19 IV Non-US Vaccine (COVAXIN)
    503COVID-19 LAV Non-US Vaccine (COVIVAC)
    504COVID-19 VVnr Non-US Vaccine (Sputnik Light)
    505COVID-19 VVnr Non-US Vaccine (Sputnik V)
    506COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
    507COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
    508COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
    509COVID-19 PS Non-US Vaccine (EpiVacCorona)
    510COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
    511COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
    215Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
    216Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
    219COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
    217COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
    218COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
    220HepB recombinant, 3-antigen, Al(OH)3
    221COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
    222Tick-borne encephalitis, unspecified
    223Tick-borne encephalitis, inactivated, PF, 0.25mL
    224Tick-borne encephalitis, inactivated, PF, 0.5mL
    225COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
    226COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
    512SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
    513SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
    514SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
    515SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
    516COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
    517SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
    227COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
    228COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
    229COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
    301COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
    300COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
    230COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
    518COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
    519COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
    520COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
    521COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
    231influenza, Southern Hemisphere, high-dose, quadrivalent
    303RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
    304Respiratory syncytial virus (RSV), unspecified
    305RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
    306RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
    307RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
    313COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
    308COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
    309COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
    310COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
    312COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
    311COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
    315Respiratory syncytial virus (RSV) MAB, unspecified
    314Respiratory syncytial virus (RSV) vaccine, unspecified
    316Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
    317Chikungunya live attenuated vaccine, 0.5 mL, PF
    318Anthrax, post-exposure prophylaxis
    319Anthrax vaccine, unspecified
    320Influenza, MDCK, trivalent, preservative
    321Influenza-avian, H5N8, monovalent, PF
    322Influenza-avian, H5N8, monovalent, preservative
    324Poliovirus, inactivated, fractional-dose (fIPV)
    323Influenza-avian, H5, unspecified formulation
    326RSV, mRNA, injectable, PF
    327Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
    328Meningococcal oligosaccharide (MenACWY), (MenB), PF
    329Chikungunya, VLP, recombinant, 0.8 mL, PF
    330Dengue fever, unspecified
    331Influenza, Southern Hemisphere, trivalent, PF
    325Vaccinia (smallpox, mpox), unspecified
    332RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
    333Influenza, live, trivalent, intranasal, self/caregiver admin, PF
    302COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose

 

Expansion

Expansion from tx.fhir.org based on codesystem CVX - US Vaccine Codes v20250715 (CodeSystem)

This value set contains 278 concepts

SystemCodeDisplay (en)JSONXML
http://hl7.org/fhir/sid/cvx  54adenovirus, type 4
http://hl7.org/fhir/sid/cvx  55adenovirus, type 7
http://hl7.org/fhir/sid/cvx  82adenovirus, unspecified formulation
http://hl7.org/fhir/sid/cvx  24Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis
http://hl7.org/fhir/sid/cvx  19BCG
http://hl7.org/fhir/sid/cvx  27botulinum antitoxin
http://hl7.org/fhir/sid/cvx  26cholera, unspecified formulation
http://hl7.org/fhir/sid/cvx  29CMVIG
http://hl7.org/fhir/sid/cvx  56dengue fever tetravalent
http://hl7.org/fhir/sid/cvx  12diphtheria antitoxin
http://hl7.org/fhir/sid/cvx  28DT (pediatric)
http://hl7.org/fhir/sid/cvx  20DTaP
http://hl7.org/fhir/sid/cvx  106DTaP, 5 pertussis antigens
http://hl7.org/fhir/sid/cvx  107DTaP, unspecified formulation
http://hl7.org/fhir/sid/cvx  110DTaP-Hep B-IPV
http://hl7.org/fhir/sid/cvx  50DTaP-Hib
http://hl7.org/fhir/sid/cvx  120DTaP-Hib-IPV
http://hl7.org/fhir/sid/cvx  130DTaP-IPV
http://hl7.org/fhir/sid/cvx  22DTP-Hib
http://hl7.org/fhir/sid/cvx  102DTP-Hib-Hep B
http://hl7.org/fhir/sid/cvx  57hantavirus
http://hl7.org/fhir/sid/cvx  52Hep A, adult
http://hl7.org/fhir/sid/cvx  83Hep A, ped/adol, 2 dose
http://hl7.org/fhir/sid/cvx  84Hep A, ped/adol, 3 dose
http://hl7.org/fhir/sid/cvx  31Hep A, pediatric, unspecified formulation
http://hl7.org/fhir/sid/cvx  85Hep A, unspecified formulation
http://hl7.org/fhir/sid/cvx  104Hep A-Hep B
http://hl7.org/fhir/sid/cvx  30HBIG
http://hl7.org/fhir/sid/cvx  42Hep B, adolescent/high risk infant
http://hl7.org/fhir/sid/cvx  43Hep B, adult
http://hl7.org/fhir/sid/cvx  44Hep B, high-dosage, dialysis or IC
http://hl7.org/fhir/sid/cvx  45Hep B, unspecified formulation
http://hl7.org/fhir/sid/cvx  58Hep C
http://hl7.org/fhir/sid/cvx  59Hep E
http://hl7.org/fhir/sid/cvx  60herpes simplex 2
http://hl7.org/fhir/sid/cvx  46Hib (PRP-D)
http://hl7.org/fhir/sid/cvx  47Hib (HbOC)
http://hl7.org/fhir/sid/cvx  48Hib (PRP-T)
http://hl7.org/fhir/sid/cvx  49Hib (PRP-OMP)
http://hl7.org/fhir/sid/cvx  17Hib, unspecified formulation
http://hl7.org/fhir/sid/cvx  51Hib-Hep B
http://hl7.org/fhir/sid/cvx  61HIV
http://hl7.org/fhir/sid/cvx  118HPV, bivalent
http://hl7.org/fhir/sid/cvx  62HPV, quadrivalent
http://hl7.org/fhir/sid/cvx  86IG
http://hl7.org/fhir/sid/cvx  87IGIV
http://hl7.org/fhir/sid/cvx  14IG, unspecified formulation
http://hl7.org/fhir/sid/cvx  111Influenza, live, trivalent, intranasal, PF
http://hl7.org/fhir/sid/cvx  15influenza, split (incl. purified surface antigen)
http://hl7.org/fhir/sid/cvx  16influenza, whole
http://hl7.org/fhir/sid/cvx  88influenza, unspecified formulation
http://hl7.org/fhir/sid/cvx  123influenza, H5N1-1203
http://hl7.org/fhir/sid/cvx  10IPV
http://hl7.org/fhir/sid/cvx  89polio, unspecified formulation
http://hl7.org/fhir/sid/cvx  39Japanese encephalitis SC
http://hl7.org/fhir/sid/cvx  63Junin virus
http://hl7.org/fhir/sid/cvx  64leishmaniasis
http://hl7.org/fhir/sid/cvx  65leprosy
http://hl7.org/fhir/sid/cvx  66Lyme disease
http://hl7.org/fhir/sid/cvx  94MMRV
http://hl7.org/fhir/sid/cvx  67malaria
http://hl7.org/fhir/sid/cvx  68melanoma
http://hl7.org/fhir/sid/cvx  32meningococcal MPSV4
http://hl7.org/fhir/sid/cvx  103meningococcal C conjugate
http://hl7.org/fhir/sid/cvx  114meningococcal MCV4P
http://hl7.org/fhir/sid/cvx  108meningococcal ACWY, unspecified formulation
http://hl7.org/fhir/sid/cvx  69parainfluenza-3
http://hl7.org/fhir/sid/cvx  11pertussis
http://hl7.org/fhir/sid/cvx  23plague
http://hl7.org/fhir/sid/cvx  33pneumococcal polysaccharide PPV23
http://hl7.org/fhir/sid/cvx  100pneumococcal conjugate PCV 7
http://hl7.org/fhir/sid/cvx  109pneumococcal, unspecified formulation
http://hl7.org/fhir/sid/cvx  70Q fever
http://hl7.org/fhir/sid/cvx  18rabies, intramuscular injection
http://hl7.org/fhir/sid/cvx  40rabies, intradermal injection
http://hl7.org/fhir/sid/cvx  90rabies, unspecified formulation
http://hl7.org/fhir/sid/cvx  72rheumatic fever
http://hl7.org/fhir/sid/cvx  73Rift Valley fever
http://hl7.org/fhir/sid/cvx  34RIG
http://hl7.org/fhir/sid/cvx  119rotavirus, monovalent
http://hl7.org/fhir/sid/cvx  122rotavirus, unspecified formulation
http://hl7.org/fhir/sid/cvx  116rotavirus, pentavalent
http://hl7.org/fhir/sid/cvx  74rotavirus, tetravalent
http://hl7.org/fhir/sid/cvx  71RSV-IGIV
http://hl7.org/fhir/sid/cvx  93RSV-MAb
http://hl7.org/fhir/sid/cvx  38rubella/mumps
http://hl7.org/fhir/sid/cvx  76Staphylococcus bacterio lysate
http://hl7.org/fhir/sid/cvx  113Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
http://hl7.org/fhir/sid/cvx  115Tdap
http://hl7.org/fhir/sid/cvx  35tetanus toxoid, adsorbed
http://hl7.org/fhir/sid/cvx  112tetanus toxoid, unspecified formulation
http://hl7.org/fhir/sid/cvx  77Tick-borne encephalitis vaccine (non-US)
http://hl7.org/fhir/sid/cvx  13TIG
http://hl7.org/fhir/sid/cvx  95TST-OT tine test
http://hl7.org/fhir/sid/cvx  96TST-PPD intradermal
http://hl7.org/fhir/sid/cvx  97TST-PPD tine test
http://hl7.org/fhir/sid/cvx  98TST, unspecified formulation
http://hl7.org/fhir/sid/cvx  78tularemia vaccine
http://hl7.org/fhir/sid/cvx  91typhoid, unspecified formulation
http://hl7.org/fhir/sid/cvx  25typhoid, oral
http://hl7.org/fhir/sid/cvx  41typhoid, parenteral
http://hl7.org/fhir/sid/cvx  53typhoid, parenteral, AKD (U.S. military)
http://hl7.org/fhir/sid/cvx  101typhoid, ViCPs
http://hl7.org/fhir/sid/cvx  75Vaccinia (smallpox, mpox), live
http://hl7.org/fhir/sid/cvx  105vaccinia (smallpox) diluted
http://hl7.org/fhir/sid/cvx  79vaccinia immune globulin
http://hl7.org/fhir/sid/cvx  21varicella
http://hl7.org/fhir/sid/cvx  81VEE, inactivated
http://hl7.org/fhir/sid/cvx  80VEE, live
http://hl7.org/fhir/sid/cvx  92VEE, unspecified formulation
http://hl7.org/fhir/sid/cvx  36VZIG
http://hl7.org/fhir/sid/cvx  117VZIG (IND)
http://hl7.org/fhir/sid/cvx  37yellow fever live
http://hl7.org/fhir/sid/cvx  121zoster live
http://hl7.org/fhir/sid/cvx  998no vaccine administered
http://hl7.org/fhir/sid/cvx  999unknown
http://hl7.org/fhir/sid/cvx  99RESERVED - do not use
http://hl7.org/fhir/sid/cvx  133Pneumococcal conjugate PCV 13
http://hl7.org/fhir/sid/cvx  134Japanese Encephalitis IM
http://hl7.org/fhir/sid/cvx  137HPV, unspecified formulation
http://hl7.org/fhir/sid/cvx  136Meningococcal MCV4O
http://hl7.org/fhir/sid/cvx  135Influenza, high-dose, trivalent, PF
http://hl7.org/fhir/sid/cvx  131typhus, historical
http://hl7.org/fhir/sid/cvx  132DTaP-IPV-HIB-HEP B, historical
http://hl7.org/fhir/sid/cvx  128Novel Influenza-H1N1-09, all formulations
http://hl7.org/fhir/sid/cvx  125Novel Influenza-H1N1-09, nasal
http://hl7.org/fhir/sid/cvx  126Novel influenza-H1N1-09, preservative-free
http://hl7.org/fhir/sid/cvx  127Novel influenza-H1N1-09
http://hl7.org/fhir/sid/cvx  138Td (adult)
http://hl7.org/fhir/sid/cvx  139Td(adult) unspecified formulation
http://hl7.org/fhir/sid/cvx  140Influenza, split virus, trivalent, PF
http://hl7.org/fhir/sid/cvx  129Japanese Encephalitis, unspecified formulation
http://hl7.org/fhir/sid/cvx  141Influenza, split virus, trivalent, preservative
http://hl7.org/fhir/sid/cvx  142tetanus toxoid, not adsorbed
http://hl7.org/fhir/sid/cvx  143Adenovirus types 4 and 7
http://hl7.org/fhir/sid/cvx  144influenza, seasonal, intradermal, preservative free
http://hl7.org/fhir/sid/cvx  145RSV-MAb (new)
http://hl7.org/fhir/sid/cvx  146DTaP,IPV,Hib,HepB
http://hl7.org/fhir/sid/cvx  147meningococcal MCV4, unspecified formulation
http://hl7.org/fhir/sid/cvx  148Meningococcal C/Y-HIB PRP
http://hl7.org/fhir/sid/cvx  149Influenza, live, quadrivalent, intranasal
http://hl7.org/fhir/sid/cvx  150Influenza, split virus, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  151influenza nasal, unspecified formulation
http://hl7.org/fhir/sid/cvx  152Pneumococcal Conjugate, unspecified formulation
http://hl7.org/fhir/sid/cvx  153Influenza, MDCK, trivalent, PF
http://hl7.org/fhir/sid/cvx  154Hep A, IG
http://hl7.org/fhir/sid/cvx  155Influenza, recombinant, trivalent, PF
http://hl7.org/fhir/sid/cvx  156Rho(D)-IG
http://hl7.org/fhir/sid/cvx  157Rho(D) -IG IM
http://hl7.org/fhir/sid/cvx  158Influenza, split virus, quadrivalent, preservative
http://hl7.org/fhir/sid/cvx  159Rho(D) - Unspecified formulation
http://hl7.org/fhir/sid/cvx  160Influenza A monovalent (H5N1), ADJUVANTED-2013
http://hl7.org/fhir/sid/cvx  801AS03 Adjuvant
http://hl7.org/fhir/sid/cvx  161Influenza, injectable,quadrivalent, preservative free, pediatric
http://hl7.org/fhir/sid/cvx  162meningococcal B, recombinant
http://hl7.org/fhir/sid/cvx  163meningococcal B, OMV
http://hl7.org/fhir/sid/cvx  164meningococcal B, unspecified
http://hl7.org/fhir/sid/cvx  165HPV9
http://hl7.org/fhir/sid/cvx  166influenza, intradermal, quadrivalent, preservative free
http://hl7.org/fhir/sid/cvx  167meningococcal, unknown serogroups
http://hl7.org/fhir/sid/cvx  168Influenza, adjuvanted, trivalent, PF
http://hl7.org/fhir/sid/cvx  169Hep A, live attenuated
http://hl7.org/fhir/sid/cvx  170DTAP/IPV/HIB - non-US
http://hl7.org/fhir/sid/cvx  171Influenza, MDCK, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  172cholera, WC-rBS
http://hl7.org/fhir/sid/cvx  173cholera, BivWC
http://hl7.org/fhir/sid/cvx  174cholera, live attenuated
http://hl7.org/fhir/sid/cvx  175Rabies - IM Diploid cell culture
http://hl7.org/fhir/sid/cvx  176Rabies - IM fibroblast culture
http://hl7.org/fhir/sid/cvx  177PCV10
http://hl7.org/fhir/sid/cvx  178OPV bivalent
http://hl7.org/fhir/sid/cvx  179OPV ,monovalent, unspecified
http://hl7.org/fhir/sid/cvx  180tetanus immune globulin
http://hl7.org/fhir/sid/cvx  181anthrax immune globulin
http://hl7.org/fhir/sid/cvx  182OPV, Unspecified
http://hl7.org/fhir/sid/cvx  183Yellow fever vaccine live - alt
http://hl7.org/fhir/sid/cvx  184Yellow fever, unspecified
http://hl7.org/fhir/sid/cvx  185Influenza, recombinant, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  186Influenza, MDCK, quadrivalent, preservative
http://hl7.org/fhir/sid/cvx  187zoster recombinant
http://hl7.org/fhir/sid/cvx  188zoster, unspecified formulation
http://hl7.org/fhir/sid/cvx  189HepB-CpG
http://hl7.org/fhir/sid/cvx  190Typhoid conjugate vaccine (TCV)
http://hl7.org/fhir/sid/cvx  191meningococcal A polysaccharide (non-US)
http://hl7.org/fhir/sid/cvx  192meningococcal AC polysaccharide (non-US)
http://hl7.org/fhir/sid/cvx  193Hep A-Hep B, pediatric/adolescent
http://hl7.org/fhir/sid/cvx  194Influenza, Southern Hemisphere
http://hl7.org/fhir/sid/cvx  195DT, IPV adsorbed
http://hl7.org/fhir/sid/cvx  196Td, adsorbed, preservative free, adult use, Lf unspecified
http://hl7.org/fhir/sid/cvx  197Influenza, high-dose, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  200influenza, Southern Hemisphere, pediatric, preservative free
http://hl7.org/fhir/sid/cvx  201Influenza, Southern Hemisphere, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  202influenza, Southern Hemisphere, quadrivalent, with preservative
http://hl7.org/fhir/sid/cvx  198DTP-hepB-Hib Pentavalent Non-US
http://hl7.org/fhir/sid/cvx  203meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
http://hl7.org/fhir/sid/cvx  205Influenza, adjuvanted, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  206Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
http://hl7.org/fhir/sid/cvx  207COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
http://hl7.org/fhir/sid/cvx  208COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx  213SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
http://hl7.org/fhir/sid/cvx  210COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx  212COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx  204Ebola Zaire vaccine, live, recombinant, 1mL dose
http://hl7.org/fhir/sid/cvx  214Ebola, unspecified
http://hl7.org/fhir/sid/cvx  211COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx  500COVID-19 Non-US Vaccine, Product Unknown
http://hl7.org/fhir/sid/cvx  501COVID-19 IV Non-US Vaccine (QAZCOVID-IN)
http://hl7.org/fhir/sid/cvx  502COVID-19 IV Non-US Vaccine (COVAXIN)
http://hl7.org/fhir/sid/cvx  503COVID-19 LAV Non-US Vaccine (COVIVAC)
http://hl7.org/fhir/sid/cvx  504COVID-19 VVnr Non-US Vaccine (Sputnik Light)
http://hl7.org/fhir/sid/cvx  505COVID-19 VVnr Non-US Vaccine (Sputnik V)
http://hl7.org/fhir/sid/cvx  506COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
http://hl7.org/fhir/sid/cvx  507COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
http://hl7.org/fhir/sid/cvx  508COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
http://hl7.org/fhir/sid/cvx  509COVID-19 PS Non-US Vaccine (EpiVacCorona)
http://hl7.org/fhir/sid/cvx  510COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
http://hl7.org/fhir/sid/cvx  511COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
http://hl7.org/fhir/sid/cvx  215Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
http://hl7.org/fhir/sid/cvx  216Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
http://hl7.org/fhir/sid/cvx  219COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx  217COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx  218COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx  220HepB recombinant, 3-antigen, Al(OH)3
http://hl7.org/fhir/sid/cvx  221COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx  222Tick-borne encephalitis, unspecified
http://hl7.org/fhir/sid/cvx  223Tick-borne encephalitis, inactivated, PF, 0.25mL
http://hl7.org/fhir/sid/cvx  224Tick-borne encephalitis, inactivated, PF, 0.5mL
http://hl7.org/fhir/sid/cvx  225COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
http://hl7.org/fhir/sid/cvx  226COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
http://hl7.org/fhir/sid/cvx  512SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
http://hl7.org/fhir/sid/cvx  513SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
http://hl7.org/fhir/sid/cvx  514SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
http://hl7.org/fhir/sid/cvx  515SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
http://hl7.org/fhir/sid/cvx  516COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
http://hl7.org/fhir/sid/cvx  517SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
http://hl7.org/fhir/sid/cvx  227COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx  228COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx  229COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx  301COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
http://hl7.org/fhir/sid/cvx  300COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx  230COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
http://hl7.org/fhir/sid/cvx  518COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
http://hl7.org/fhir/sid/cvx  519COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
http://hl7.org/fhir/sid/cvx  520COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
http://hl7.org/fhir/sid/cvx  521COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
http://hl7.org/fhir/sid/cvx  231influenza, Southern Hemisphere, high-dose, quadrivalent
http://hl7.org/fhir/sid/cvx  303RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
http://hl7.org/fhir/sid/cvx  304Respiratory syncytial virus (RSV), unspecified
http://hl7.org/fhir/sid/cvx  305RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
http://hl7.org/fhir/sid/cvx  306RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
http://hl7.org/fhir/sid/cvx  307RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
http://hl7.org/fhir/sid/cvx  313COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
http://hl7.org/fhir/sid/cvx  308COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx  309COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx  310COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx  312COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
http://hl7.org/fhir/sid/cvx  311COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
http://hl7.org/fhir/sid/cvx  315Respiratory syncytial virus (RSV) MAB, unspecified
http://hl7.org/fhir/sid/cvx  314Respiratory syncytial virus (RSV) vaccine, unspecified
http://hl7.org/fhir/sid/cvx  316Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
http://hl7.org/fhir/sid/cvx  317Chikungunya live attenuated vaccine, 0.5 mL, PF
http://hl7.org/fhir/sid/cvx  318Anthrax, post-exposure prophylaxis
http://hl7.org/fhir/sid/cvx  319Anthrax vaccine, unspecified
http://hl7.org/fhir/sid/cvx  320Influenza, MDCK, trivalent, preservative
http://hl7.org/fhir/sid/cvx  321Influenza-avian, H5N8, monovalent, PF
http://hl7.org/fhir/sid/cvx  322Influenza-avian, H5N8, monovalent, preservative
http://hl7.org/fhir/sid/cvx  324Poliovirus, inactivated, fractional-dose (fIPV)
http://hl7.org/fhir/sid/cvx  323Influenza-avian, H5, unspecified formulation
http://hl7.org/fhir/sid/cvx  326RSV, mRNA, injectable, PF
http://hl7.org/fhir/sid/cvx  327Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
http://hl7.org/fhir/sid/cvx  328Meningococcal oligosaccharide (MenACWY), (MenB), PF
http://hl7.org/fhir/sid/cvx  329Chikungunya, VLP, recombinant, 0.8 mL, PF
http://hl7.org/fhir/sid/cvx  330Dengue fever, unspecified
http://hl7.org/fhir/sid/cvx  331Influenza, Southern Hemisphere, trivalent, PF
http://hl7.org/fhir/sid/cvx  325Vaccinia (smallpox, mpox), unspecified
http://hl7.org/fhir/sid/cvx  332RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
http://hl7.org/fhir/sid/cvx  333Influenza, live, trivalent, intranasal, self/caregiver admin, PF
http://hl7.org/fhir/sid/cvx  302COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code